Nuclear resonance vibrational spectroscopic and computational study of high-valent diiron complexes relevant to enzyme intermediates

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 16, 2013, Pages 6275-6280

  Park, Kiyoung ^a   Bell III, Caleb B ^a   Liu, Lei V ^a   Wang, Dong ^b,g   Xue, Genqiang ^b   Kwak, Yeonju ^a   Wong, Shaun D ^a   Light, Kenneth M ^a   Zhao, Jiyong ^c   Alp, E Ercan ^c   Yoda, Yoshitaka ^d   Saito, Makina ^e   Kobayashi, Yasuhiro ^e   Ohta, Takehiro ^f   Seto, Makoto ^e   Que, Lawrence ^b   Solomon, Edward I ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c ARGONNE NATIONAL LABORATORY   (United States)

^d JAPAN SYNCHROTRON RADIATION RESEARCH INSTITUTE   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

^g PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; FERROUS ION; IRON COMPLEX;

ACCELERATION; ARTICLE; CHEMICAL STRUCTURE; COMPLEX FORMATION; COMPUTATIONAL FLUID DYNAMICS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DENSITY FUNCTIONAL THEORY; ENZYME ACTIVITY; ENZYME SPECIFICITY; MASS SPECTROMETRY; NUCLEAR RESONANCE VIBRATIONAL SPECTROSCOPY; OXIDATION; PRIORITY JOURNAL; VIBRATION;

EID: 84876252500     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1304238110     Document Type: Article

References (38)

1. StubbeJ (2003) Di-iron-tyrosyl radical ribonucleotide reductases. CurrOpin Chem Biol 7(2):183-188.
2. Tinberg CE, Lippard SJ (2011) Dioxygen activation in soluble methane mono-oxygenase. Acc Chem Res 44(4):280-288.
3. Shao J, Zhou B, Chu B, Yen Y (2006) Ribonucleotide reductase inhibitors and future drug design. Curr Cancer Drug Targets 6(5):409-431.
4. Lee SW, Keeney DR, Lim DH, Dispirito AA, Semrau JD (2006) Mixed pollutant degradation by Methylosinus trichosporium OB3b expressing either soluble or particulate methane monooxygenase: can the tortoise beat the hare? Appl Environ Microbiol 72(12):7503-7509.
5. Baldwin J, et al. (2000) Mechanism of rapid electron transfer during oxygen activation in the R2 subunit of escherichia coli ribonucleotide reductase. 1. Evidence for a transient tryptophan radical. J Am Chem Soc 122:12195-12206.
6. 2+ reaction by optical, EPR, and Mossbauer spectroscopies. J Am Chem Soc 116:8024-8032.
7. Brazeau BJ, Lipscomb JD (2000) Kinetics and activation thermodynamics of methane monooxygenase compound Q formation and reaction with substrates. Biochemistry 39(44):13503-13515.
8. Tinberg CE, Lippard SJ (2010) Oxidation reactions performed by soluble methane monooxygenase hydroxylase intermediates H(peroxo) and Q proceed by distinct mechanisms. Biochemistry 49(36):7902-7912.
9. Sturgeon BE, et al. (1996) Reconsideration of X, the diiron intermediate formed during cofactor assembly in E. coli ribonucleotide reductase. J Am Chem Soc 118:7551-7557.
10. IV cluster. J Am Chem Soc 115:6450-6451.
11. Riggs-Gelasco P, et al. (1998) EXAFS characterization of the intermediate X generated during the assembly of the escherichia coli ribonucleotide reductase R2 diferrictyrosyl radical cofactor. J Am Chem Soc 120:849-860.
12. 2 diamond core structure for the key intermediate Q of methane monooxygenase. Science 275(5299):515-518.
13. Siegbahn PEM (1999) Theoretical model studies of the iron dimer complex of MMO and RNR. Inorg Chem 38(12):2880-2889.
14. Han WG, Noodleman L (2011) DFT calculations for intermediate and active states of the diiron center with a tryptophan or tyrosine radical in Escherichia coli ribonucleotide reductase. Inorg Chem 50(6):2302-2320.
15. Han WG, Noodleman L (2009) DFT calculations of comparative energetics and ENDOR/Mössbauer properties for two protonation states of the iron dimer cluster of ribonucleotide reductase intermediate X. Dalton Trans 30(30):6045-6057.
16. Shanmugam M, Doan PE, Lees NS, Stubbe J, Hoffman BM (2009) Identification of protonated oxygenic ligands of ribonucleotide reductase intermediate X. J Am Chem Soc 131(9):3370-3376.
17. Mitic N, Clay MD, Saleh L, Bollinger JM, Jr., Solomon EI (2007) Spectroscopic and electronic structure studies of intermediate X in ribonucleotide reductase R2 and two variants: a description of the FeIV-oxo bond in the FeIII-O-FeIV dimer. J Am Chem Soc 129(29):9049-9065.
18. Han WG, Noodleman L (2008) Structural model studies for the high-valent intermediate Q of methane monooxygenase from broken-symmetry density functional calculations. Inorg Chim Acta 361(4):973-986.
19. Baik MH, Gherman BF, Friesner RA, Lippard SJ (2002) Hydroxylation of methane by non-heme diiron enzymes: molecular orbital analysis of C-H bond activation by reactive intermediate Q. J Am Chem Soc 124(49):14608-14615.
20. Siegbahn PEM, Crabtree RH (1997) Mechanism of C-H activation by diiron methane monooxygenases: Quantum chemical studies. J Am Chem Soc 119:3103-3113.
21. Lee SK, Nesheim JC, Lipscomb JD (1993) Transient intermediates of the methane monooxygenase catalytic cycle. J Biol Chem 268(29):21569-21577.
22. Seto M, Yoda Y, Kikuta S, Zhang XW, Ando M (1995) Observation of nuclear resonant scattering accompanied by phonon excitation using synchrotron radiation. Phys Rev Lett 74(19):3828-3831.
23. Sturhahn W, et al. (1995) Phonon density of states measured by inelastic nuclear resonant scattering. Phys Rev Lett 74(19):3832-3835.
24. Alp EE, Mooney TM, Toellner T, Sturhahn W (1994) Nuclear resonant scattering beamline at the advanced photon source. Hyperfine Interact 90:323-334.
25. Sturhahn W (2004) Nuclear resonant spectroscopy. J Phys Condens Matter 16: S497-S530.
26. Scheidt WR, Durbin SM, Sage JT (2005) Nuclear resonance vibrational spectroscopy- NRVS. J Inorg Biochem 99(1):60-71.
27. Liu LV, et al. (2010) Definition of the intermediates and mechanism of the anticancer drug bleomycin using nuclear resonance vibrational spectroscopy and related methods. Proc Natl Acad Sci USA 107(52):22419-22424.
28. 3tren: Experimentally calibrated insights into reactivity. Angew Chem Int Ed 50:3215-3218.
29. Park K, et al. (2013) NRVS and DFT study of peroxo-bridged biferric complexes: Structural insight into peroxy intermediates of binuclear non-heme iron enzymes. Angew Chem Int Ed 52:1294-1298.
30. Wang D, Farquhar ER, Stubna A, Münck E, Que L (2009) A diiron(IV) complex that cleaves strong C-H and O-H bonds. Nat Chem 1(2):145-150.
31. 2] diamond core proposed for methane monooxygenase intermediate Q. Proc Natl Acad Sci USA 104(52): 20713-20718.
32. 3. J Am Chem Soc 117:2778-2792.
33. 2 diamond core. Implications for the core structures of methane monooxygenase intermediate Q and ribonucleotide reductase intermediate X. J Am Chem Soc 121:5230-5237.
34. Sanders-Loehr J, et al. (1989) Electronic and Raman spectroscopic properties of oxo-bridged dinuclear iron centers in proteins and model compounds. J Am Chem Soc 111:8084-8093.
35. 2 "diamond" core. J Am Chem Soc 120:955-962.
36. Sturhahn W (2000) CONUSS and PHOENIX: Evaluation of nuclear resonant scattering data. Hyperfine Interact 125:149-172.
37. Frisch MJ, et al. (2010) Gaussian 09, revision B.01.
38. Whittington DA, Lippard SJ (2001) Crystal structures of the soluble methane monooxygenase hydroxylase from Methylococcus capsulatus (Bath) demonstrating geometrical variability at the dinuclear iron active site. J Am Chem Soc 123(5):827-838.